Back to Agenda
Participant Compensation in Clinical Trials: Exploring Today’s Landscape and Unlocking Opportunities
Session Chair(s)
Carie Pierce, MS
SVP & Global Head of Growth
DIA, United States
In a rapidly evolving clinical trial landscape, breaking down financial barriers is essential to foster participant enrollment, improve retention, and ensure the success of trials.
Learning Objective : Identify key findings from DIA’s Participant Compensation Landscape Analysis and discuss their implications to promote diversity and support clinical trial outcomes; Recognize participant-centric strategies to address financial barriers in clinical research, enhancing diversity in trial participation; Discuss collaborative approaches to further understand participant compensation practices.
Speaker(s)
Moderator
Donna Libretti Cooke, JD
ImpactSphere Clinical, LLC, United States
Chief Impact Officer & Owner
Panelist
James Lovett, JD
Myonex, United States
CEO
Contributor-Industry
Karen Correa, PHD
Boehringer Ingelheim, United States
Vice President, Clinical Development Operations
Contributor-Academia
Kenneth Getz, MBA
Tufts University School of Medicine, United States
Tufts Center for the Study of Drug Development
Have an account?